CFO
CLX icon

Callan Family Office’s Clorox CLX Stock Holding History

Callan Family Office’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,336
Closed -$242K – 1230
2026
Q1 		$242K Sell
2,336
-527
-18% -$59.7K 0.01% 997
2025
Q4 		$289K Buy
+2,863
New +$311K 0.01% 940
2025
Q3 		– Sell
-2,638
Closed -$317K – 867
2025
Q2 		$317K Buy
+2,638
New +$352K 0.01% 748
2025
Q1 		– Sell
-1,492
Closed -$242K – 568
2024
Q4 		$242K Buy
+1,492
New +$244K 0.02% 550

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Callan Family Office's CLX Position: Q2 2026 in Review

Callan Family Office sold out of Clorox (CLX) in Q2 2026, closing a stake of 2,336 shares — an estimated $242K sold.

Callan Family Office first reported a position in CLX in Q4 2024 and held it in 4 quarters. The position peaked at $317K in Q2 2025. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Callan Family Office reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
  • Callan Family Office sold 2,336 Clorox shares in Q2 2026, an estimated $242K.
  • Callan Family Office first reported a position in Clorox in Q4 2024 and held it in 4 quarters.
  • Callan Family Office's Clorox position peaked at $317K in Q2 2025.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.